Compare Gem Aromatics with Similar Stocks
Dashboard
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 10.04
Poor long term growth as Net Sales has grown by an annual rate of 11.40% and Operating profit at 12.51% over the last 5 years
The company has declared Negative results for the last 2 consecutive quarters
With ROCE of 14.6, it has a Attractive valuation with a 2.1 Enterprise value to Capital Employed
Falling Participation by Institutional Investors
Underperformed the market in the last 1 year
Stock DNA
Specialty Chemicals
INR 1,050 Cr (Micro Cap)
18.00
38
0.00%
0.18
12.35%
2.28
Total Returns (Price + Dividend) 
Gem Aromatics for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Gem Aromatics Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials
Gem Aromatics Ltd, a player in the Specialty Chemicals sector, has seen its investment rating upgraded from Sell to Hold as of 4 March 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends despite recent quarterly setbacks. The company’s evolving market dynamics and operational metrics warrant a closer look for investors seeking balanced exposure in this micro-cap chemical stock.
Read full news article
Gem Aromatics Ltd Shows Signs of Technical Momentum Shift Amid Specialty Chemicals Sector Recovery
Gem Aromatics Ltd, a player in the Specialty Chemicals sector, has recently exhibited a shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a series of technical indicator signals and a notable improvement in its MarketsMOJO rating, signalling a potential turning point for investors.
Read full news article
Gem Aromatics Ltd Shows Mixed Technical Signals Amid Sideways Momentum
Gem Aromatics Ltd, a key player in the Specialty Chemicals sector, has exhibited a notable shift in its technical momentum, reflecting a complex interplay of bullish and neutral signals. Despite a recent upgrade in daily price momentum, broader weekly and monthly technical indicators suggest a sideways trend, prompting a cautious outlook for investors amid volatile market conditions.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Press Release / Media Release
26-Feb-2026 | Source : BSEDisclosure under Regulation 30 of the SEBI (LODR) Regulations 2015.
Intimation Of Commercial Production
26-Feb-2026 | Source : BSEDisclosure under Regulation 30 of the SEBI (LODR) Regulations 2015.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12-Feb-2026 | Source : BSEIntimation of Plant visit.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 9 FIIs (0.79%)
Parekh Family Trust (20.29%)
Doterra Enterprises S.a.r.l (18.36%)
17.01%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -14.74% vs 28.80% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 2.43% vs -36.96% in Sep 2025






